Literature DB >> 16833136

Field evaluation of an avian risk assessment model.

Nimish B Vyas1, James W Spann, Craig S Hulse, Shannon L Borges, Richard S Bennett, Martin Torrez, Bruce I Williams, Robert Leffel.   

Abstract

We conducted two laboratory subacute dietary toxicity tests and one outdoor subacute dietary toxicity test to determine the effectiveness of the U.S. Environmental Protection Agency's deterministic risk assessment model for evaluating the potential of adverse effects to birds in the field. We tested technical-grade diazinon and its D.Z.N 50W (50% diazinon active ingredient wettable powder) formulation on Canada goose (Branta canadensis) goslings. Brain acetylcholinesterase activity was measured, and the feathers and skin, feet, and gastrointestinal contents were analyzed for diazinon residues. The dose-response curves showed that diazinon was significantly more toxic to goslings in the outdoor test than in the laboratory tests. The deterministic risk assessment method identified the potential for risk to birds in general, but the factors associated with extrapolating from the laboratory to the field, and from the laboratory test species to other species, resulted in the underestimation of risk to the goslings. The present study indicates that laboratory-based risk quotients should be interpreted with caution.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16833136     DOI: 10.1897/05-230r.1

Source DB:  PubMed          Journal:  Environ Toxicol Chem        ISSN: 0730-7268            Impact factor:   3.742


  2 in total

1.  Dermal insecticide residues from birds inhabiting an orchard.

Authors:  Nimish B Vyas; James W Spann; Craig S Hulse; Sallie Gentry; Shannon L Borges
Journal:  Environ Monit Assess       Date:  2006-12-14       Impact factor: 2.513

2.  The influence of study species selection on estimates of pesticide exposure in free-ranging birds.

Authors:  Shannon L Borges; Nimish B Vyas; Mary C Christman
Journal:  Environ Manage       Date:  2013-10-31       Impact factor: 3.266

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.